Cargando…
Decavanadate Toxicology and Pharmacological Activities: V(10) or V(1), Both or None?
This review covers recent advances in the understanding of decavanadate toxicology and pharmacological applications. Toxicological in vivo studies point out that V(10) induces several changes in several oxidative stress parameters, different from the ones observed for vanadate (V(1)). In in vitro st...
Autor principal: | Aureliano, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745863/ https://www.ncbi.nlm.nih.gov/pubmed/26904166 http://dx.doi.org/10.1155/2016/6103457 |
Ejemplares similares
-
Rationalizing the Decavanadate(V) and Oxidovanadium(IV)
Binding to G-Actin and the Competition with Decaniobate(V)
and ATP
por: Sciortino, Giuseppe, et al.
Publicado: (2020) -
Hexakis(tetraaquasodium) decavanadate(V) dihydrate
por: Nilsson, Jessica, et al.
Publicado: (2010) -
Pharmacological and Toxicological Threshold of Bisammonium Tetrakis 4-(N,N-Dimethylamino)pyridinium Decavanadate in a Rat Model of Metabolic Syndrome and Insulin Resistance
por: Treviño, Samuel, et al.
Publicado: (2018) -
Nonapiperidinium monohydrogen decavanadate tetranitrate
por: Graia, Mohsen, et al.
Publicado: (2009) -
Tris(2-Pyridylmethylamine)V(O)(2) Complexes as Counter Ions of Diprotonated Decavanadate Anion: Potential Antineoplastic Activity
por: Corona-Motolinia, Nidia D., et al.
Publicado: (2022)